Page 132 - Read Online
P. 132

usual recommended dose for albendazole is 15 mg/kg   circumstances  and  that albendazole and praziquantel
           per day divided into two doses every 12 h for 1 week   have  equivalent  efficacy  at  different  stages  of  the
                                                         [10]
           while the duration of antihelminthic therapy varies.    disease. We suggest that the combination antihelminthic
           In this case, our patient started on albendazole at a low   treatment of albendazole and praziquantel has potential
           dose when he had multiple parenchymal cysts. After a   benefits for patients with multiple cysticercus cysts in
           2-cycle treatment of albendazole, the perilesional   brain.
           oedema faded away, the number of large cysts reduced
           to one, and most of the cysts became calcified nodules.   Financial support and sponsorship
           In contrast with most neurocysticercosis cases, where   Nil.
           only one type of antihelminthic drugs is given, we
           utilized praziquantel to target a single unremitting large   Conflicts of interest
           cyst. Praziquantel can destroy cysticercus cysts in   There are no conflicts of interest.
           parenchymal  brain by changing  the  metabolism  of   REFERENCES
           intracellular calcium. It has been pointed out that
           praziquantel is favoured in patients with lower cyst   1.   Mamkin I, Sood N, Ramanan SV. Taenia solium neurocysticercosis. N Engl
           burdens, while the multiple cysts barely changed after   J Med 2007;357:1666-7.
           short course of praziquantel introduced by Pretell  et   2.   Osvaldo  MT,  Newton  SO,  Pierina  SB,  Jose  EL,  Vera  LL.  Medical
                                                                  management of neurocycsticercosis.  Expert Opin Pharmacother
           al.  In contrast to albendazole, praziquantel is       2011;12:2845-56.
             [11]
           associated with more frequent adverse reactions (e.g.   3.   Singh G1, Burneo JG, Sander JW. From seizures to epilepsy and its
                                                                  substrates: neurocysticercosis. Epilepsia 2013;54:783-92.
           headache and vomiting). However, after another 2-cycle   4.   Nash TE, Del Brutto OH, Butman JA, Corona T, Delgado-Escueta A,
           treatment of praziquantel in this case, the large cyst in   Duron RM, Evans CA, Gilman RH, Gonzalez AE, Loeb JA, Medina MT,
           the right basal ganglia region had dramatically resolved   Pietsch-Escueta S, Pretell EJ, Takayanagui OM, Theodore W, Tsang VC,
                                                                  Garcia HH. Calcific neurocysticercosis and epileptogenesis.  Neurology
           without  adverse  drug  reactions.  Recent  studies  about   2004;62:1943-8.
           the relative efficacy of these two antihelminthic drugs   5.   Del Brutto OH. Diagnostic criteria for neurocysticercosis,revisited. Pathog
           seemed to demonstrate that albendazole might be the   6.   Glob Health 2012;106:299-304.
                                                                  Garcia HH, Gonzales I, Lescano AG, Bustos JA, Zimic M, Escalante D,
           drug treatment of first choice in neurocysticercosis.   Saavedra H, Gavidia M, Rodriguez L, Najar E, Umeres H, Pretell EJ;
           While praziquantel has been shown to eliminate 60-     Cysticercosis Working Group in Peru. Efficacy of combined antiparasitic
                                                                  therapy with praziquantel and albendazole for neurocysticercosis: a double-
           70% of parenchymal brain cysts, albendazole has been   blind, randomised controlled trial. Lancet Infect Dis 2014;14:687-95.
           found to destroy 80-90% of them. A  meta-analysis   7.   Kalra  V,  Dua  T,  Kumar V.  Efficacy of  albendazole  and  short-course
           revealed that albendazole was more effective than      dexamethasone treatment in children with 1 or 2 ring-enhancing lesions of
                                                                  neurocysticercosis: a randomized controlled trial. J Pediar 2003;143:111-4.
           praziquantel regarding the clinical outcomes of patients   8.   Matthaiou DK, Panos G, Adamidi ES, Falagas ME. Albendazole versus
           with neurocysticercosis.  A randomised controlled      praziquantel in the treatment of neurocysticercosis: a meta-analysis of
                                 [8]
           trial also showed the increased antihelminthic efficacy   9.   comparative trials. PLoS Negl Trop Dis 2008;2:e194.
                                                                  Gardenas G, Carrillo MR, Jung H, Sciutto E, Hernandez JL, Fleury A.
           of an albendazole plus praziquantel regimen, and that   Subarachnoidal neurocysticercosis non-reponsive to cysticidal drugs: a
                                                                  case series. BMC Neurol 2010;10:16.
           further seizures were less frequent in individuals with   10.  Takayanagui OM. Therapy forneurocysticercosis. Expert Rev Neurother
           complete   cyst  resolution  after  antihelminthic     2004;4:129-39.
                    [6]
           treatment.  On the basis of those studies and this case   11.  Pretell EJ, Garcia HH, Gilman RH, Saavedra H, Martinez M; Cysticercosis
           report, we believe that the antihelminthic therapy     Working Group in Peru. Failure of one-day praziquantel treatment in
                                                                  patients with multiple neurocysticerosis lesions.  Clin Neurol Neurosurg
           should be rationally and individually based on different   2001;103:175-7.



























           Neuroimmunol Neuroinflammation | Volume 3 | May 20, 2016                                          123
   127   128   129   130   131   132   133   134   135   136   137